Ascendis Pharma A/S Profit Margin

Ascendis Pharma A/S (ASND) currently reports a profit margin of 71.69% as of June 2026. That compares with -55.25% in the prior-year period — up 229.7% year over year. That is above the Healthcare sector average of 13.76%. Use the charts on this page to explore Ascendis Pharma A/S's profit margin history and peer comparisons.

Ascendis Pharma A/S's profit margin increased from -55.25% to 71.69% — a 229.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ascendis Pharma A/S's profit margin of 71.69% is higher than the Healthcare sector average of 13.76%. That is roughly 421.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ascendis Pharma A/S's current 71.69% should be judged against Healthcare norms (sector average: 13.76%) and against ASND's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 71.69%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Ascendis Pharma A/S, and consider following ASND for alerts when major investors trade the stock.